FILTER
LATEST INTERVIEWS
Katrin Rupalla
CEO, YMMUNOBIO
"Based on our in vivo data for our lead CEACAM1/5 antibody YB-200, we have obtained orphan drug status from FDA for the treatment of liver cancer."
Stefan Randl & Paul Spencer
HEAD OF DRUG SUBSTANCE (SR), HEAD OF DRUG DELIVERY & PRODUCT (PS), EVONIK HEALTH CARE
"The US leads innovation, so if you are not heavily invested there in pharma, you are in trouble. Lots of our clients are shifting their production from Asia, so the US will remain critical to Evonik Health Care’s growth."
Daniel Tellechea
INTERIM CEO, LARGO INC.
"We produce approximately 7% of the global vanadium supply, and on the titanium side, we are expected to produce about two thirds of the Brazilian demand for titanium pigment once the project reaches full capacity."
Eric Smith
MANAGING DIRECTOR, CEMENTATION
"Ontario has one of the highest densities of expertise in underground mining out of any of the jurisdictions we work in."
Marco Prud’Homme
PRESIDENT, NOLINOR AVIATION
"For the next 20 years, there will be lots of exploration and development in a region where there are few roads and limited sea access. So, aviation will play a crucial role in the green transition."
Dustin Angelo
PRESIDENT, CEO AND CO-FOUNDER, NOVAMERA
"There is a huge economic benefit for companies to be able to get that incremental production, because they already have all the infrastructure in place, including people, permits and mills."
Ángel Tobar
GERENTE GENERAL, EPIROC REGIÓN ANDINA
"El objetivo de Epiroc es contar con alternativas eléctricas en todos nuestros equipos subterráneos para el 2025 y en los equipos de tajo abierto para el 2030."
Dirk Lorenz-Meyer
CHAIRMAN, BEHN MEYER GROUP
"Our push towards sustainability is the common theme of all investments. We want to create a global network of integrated businesses with multiple synergies."
Peih Yoke Hoo
MANAGING DIRECTOR, LINDE (MALAYSIA)
"Supply reliability is the priority of our customers. A minute of downtime could result in losses of millions of dollars."
Roger Erickson
CEO AND FOUNDER, INTERBIOME
"We want to pioneer a commodity utility approach for needed areas of pharmaceutical manufacturing, and make that available as a sustainable platform that any country can start with and innovate from."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
Peru Mining 2025 Pre-Release II
Featuring insights from nearly 120 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting Peru’s window of opportunity to align with the global energy transition and copper’s increasingly critical role.
Featuring insights from nearly 120 mining executives, the second pre-release edition of GBR's Peru Mining 2025 sheds light on the industry's current state while highlighting Peru’s window of opportunity to align with the global energy transition and copper’s increasingly critical role.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
